Cardiac Cell Cycle Activation as a Strategy to Improve iPSC-Derived Cardiomyocyte Therapy

Circ Res. 2018 Jan 5;122(1):14-16. doi: 10.1161/CIRCRESAHA.117.312287.

¹ From the Stanford Cardiovascular Institute (J.-W.R., J.C.W.), Division of Cardiovascular Medicine, Department of Medicine (J.-W.R., J.C.W.), and Department of Radiology (J.C.W.), Stanford University School of Medicine, CA.
² From the Stanford Cardiovascular Institute (J.-W.R., J.C.W.), Division of Cardiovascular Medicine, Department of Medicine (J.-W.R., J.C.W.), and Department of Radiology (J.C.W.), Stanford University School of Medicine, CA. joewu@stanford.edu.

No abstract available

Keywords: Editorials; cell cycle; cell transplantation; heart failure; myocyte, cardiac; pluripotent stem cell.

Publication types